Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
Healthy Volunteers
NCT06682689

Investigation of TVNS Administration on Postpartum Mental Health

Led by University Hospital Tuebingen · Updated on 2024-11-12

120

Participants Needed

1

Research Sites

108 weeks

Total Duration

On this page

Sponsors

U

University Hospital Tuebingen

Lead Sponsor

G

German Center for Mental Health

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aim of the study is to explore whether transcutaneous vagus nerve stimulation (tVNS) may be effective in preventing mood swings and depressive symptoms in the postpartum phase, as well as serving as a supplementary intervention in cases where mood symptoms develop. The study will investigate the effects of tVNS intervention during the first 12 weeks postpartum. Pregnant women will be recruited for the study, and the intervention will begin shortly after giving birth. Participants will receive different instructions on how to use the tVNS device. Additional parameters such as physiological functions, chronic stress, hormones, environment, and personality traits will also be assessed.

CONDITIONS

Official Title

Investigation of TVNS Administration on Postpartum Mental Health

Who Can Participate

Age: 18Years +
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • No malformation of fetal organs detected during organ screening
  • Ability to provide written consent
  • Sufficient German language skills to understand and communicate during the study
Not Eligible

You will not qualify if you...

  • Pregnant women or those with active implants such as cochlear implants or pacemakers
  • Presence of cerebral shunts or skin problems
  • Cardiovascular issues including cardiac arrhythmias or coronary heart disease
  • Neurological disorders
  • Current mood disorder diagnosis or episode
  • Diagnosed schizophrenia spectrum or other psychotic disorders
  • Severe substance use disorders
  • Other health issues that may pose a risk to the participant or child as determined by the study clinician

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Hospital Tuebingen; Department of Psychiatry and Psychotherapy

Tübingen, Baden-Wurttemberg, Germany, 72076

Actively Recruiting

Loading map...

Research Team

J

Julia Siodmiak, M.sc.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

PREVENTION

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here